Skip to content
AlternativeMed

Laboratory Immune Effects vs Clinical Benefit

How to read headlines about changed immune cells, cytokines or antibodies, and why a lab change is not proof of fewer infections or better health, with trial examples.

Content last updated . This page has not been medically reviewed.

Quick answer
A study can show that something changes a blood marker, such as an immune-cell count, a cytokine or an antibody level, without showing that people feel better, get fewer infections or live longer. This page explains the gap. Evidence labels: preclinical (cells/animals only), promising but limited, mixed, insufficient evidence, evidence of harm. See how we label evidence.

Three levels of evidence

  1. Cells or animals. A substance changes immune cells in a dish or in mice. Label: preclinical. This cannot be assumed to apply to people.
  2. A biomarker in people. An immune marker changes in a human trial. The FDA defines a biomarker as a defined characteristic objectively measured as an indicator of normal or disease processes, or of a response to an intervention. [1]
  3. A clinical outcome in people. How people feel, function or survive, for example fewer infections. The FDA separates these from biomarkers. [1]

When can a marker stand in for an outcome?

A surrogate endpoint is a marker used as a substitute for a direct measure of how a patient feels, functions or survives. It does not measure the clinical benefit itself but is expected to predict it. [1] The FDA describes candidate surrogates as still under evaluation, and validated ones as backed by a clear mechanistic rationale and strong clinical data. [1] Most immune markers sold with supplements and wellness products are not in the validated group; we did not find a source saying otherwise. More on this at surrogate vs patient-important outcomes and biomarkers vs clinical outcomes.

Questions to ask of a headline

  • Was it done in cells, animals or people?
  • Which measure changed, and is it a validated stand-in for a health outcome?
  • Was there a comparison group, and how many people took part?
  • Did anyone measure infections, symptoms or hospital visits?
  • Who paid for it, and were harms reported?
Statistical significance is not the same as a meaningful difference: statistical vs clinical significance.

Where the evidence stops

This page does not say that immune markers are useless. Doctors use them to diagnose and monitor disease. It says a marker changed by a product or technology cannot be read as prevention or treatment of infection unless trials measured that outcome.

Frequently asked questions

Does a change in immune cells mean better protection?

Not by itself. A marker is only useful as a stand-in if studies show that it predicts a real clinical benefit. [1]

What is a surrogate endpoint?

A trial measure used instead of how a patient feels, functions or survives, expected to predict clinical benefit. [1]

Can lowering inflammation markers be harmful?

In one trial of an inflammation-targeting drug, fatal infection was higher than with placebo. [3]

Does a higher antibody level mean the herb works?

Scientists do not know whether it means any benefit, according to Harvard Health. [2]

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

Examples where marker and outcome disagreed or were not linked
  • Antibody levels. Harvard Health says scientists do not know whether an herb that seems to raise blood antibody levels is doing anything beneficial for overall immunity. [2]
  • Inflammation-lowering drug, heart patients. In CANTOS, the drug lowered high-sensitivity CRP and one dose reduced a combined heart outcome, but fatal infections were higher than with placebo and all-cause death did not differ significantly. [3] Here the lab change came with a harm.
  • Different drug, same idea. In CIRT, low-dose methotrexate did not lower interleukin-1β, interleukin-6 or CRP and did not reduce cardiovascular events. [4]
  • Supplement ingredients. A review of 39 randomized studies of eight ingredients in healthy people said evidence gaps prevented firm statements about preserving immune health. [5]
Safety and when to get help
Do not rely on a product to prevent or treat infection on the basis of a lab change. For symptoms, see a clinician; for frequent infections see getting sick often.
References
  1. US Food and Drug Administration, Surrogate Endpoint Resources for Drug and Biologic Development. Read 2026-10-22.
  2. Harvard Health Publishing, How to boost your immune system (page shows no review date). Read 2026-10-22.
  3. Ridker PM et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (CANTOS). N Engl J Med 2017. PubMed 28845751. Read 2026-10-22.
  4. Ridker PM et al. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events (CIRT). N Engl J Med 2019. PubMed 30415610. Read 2026-10-22.
  5. Crawford C et al. Select Dietary Supplement Ingredients for Preserving and Protecting the Immune System in Healthy Individuals: A Systematic Review. Nutrients 2022. PubMed 36364865. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.